| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017850063 |
| P356 | DOI | 10.1038/SJ.BMT.1703216 |
| P698 | PubMed publication ID | 11781627 |
| P5875 | ResearchGate publication ID | 11575899 |
| P2093 | author name string | Milligan DW | |
| Collingham KE | |||
| Fegan CD | |||
| Chakrabarti S | |||
| Osman H | |||
| Holder K | |||
| P2860 | cites work | The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. | Q30306426 |
| Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy | Q33731227 | ||
| Community respiratory virus infections in immunocompromised patients with cancer | Q33950804 | ||
| Parainfluenza Virus Respiratory Infection after Bone Marrow Transplantation | Q40734883 | ||
| The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation | Q40782966 | ||
| CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells | Q41622552 | ||
| Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin | Q44923546 | ||
| Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity | Q45734961 | ||
| Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy | Q45739555 | ||
| Respiratory virus infections in bone marrow transplant recipients: the European perspective | Q45741856 | ||
| Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience | Q45741859 | ||
| Community respiratory virus infections among hospitalized adult bone marrow transplant recipients | Q45769491 | ||
| Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. | Q50587442 | ||
| Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. | Q50587763 | ||
| Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. | Q50588456 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ribavirin | Q421862 |
| P304 | page(s) | 759-763 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study | |
| P478 | volume | 28 |
| Q40055495 | A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study. |
| Q90067548 | Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs |
| Q38034753 | Current management of parainfluenza pneumonitis in immunocompromised patients: a review |
| Q36558322 | Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores. |
| Q36090174 | Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection |
| Q33351623 | High-throughput screening-based identification of paramyxovirus inhibitors |
| Q30383456 | How I treat influenza in patients with hematologic malignancies. |
| Q94555435 | Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy |
| Q47611716 | Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens |
| Q43927769 | Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy. |
| Q34222907 | Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: synthesis, structure-activity relationships, and pharmacokinetics |
| Q24678611 | Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity |
| Q38558150 | Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review |
| Q42279293 | Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation |
| Q45370052 | Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation |
| Q40214692 | Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients |
| Q40590063 | Parainfluenza Virus Infection |
| Q37726073 | Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome |
| Q24682952 | Parainfluenza viruses |
| Q38105730 | Paramyxoviruses in reptiles: a review. |
| Q30412678 | Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients |
| Q92916919 | Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies |
| Q45358049 | Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin |
| Q37751364 | Respiratory viral infections in transplant and oncology patients |
| Q43577899 | Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality |
| Q42262215 | Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients |
| Q36411968 | Treatment of respiratory virus infections |
| Q38084569 | Update on viral community-acquired pneumonia. |
Search more.